West Pharmaceutical Services, Inc. (NYSE: WST), a US-based provider of solutions for injectable drug administration, announced Monday that its board of directors has declared a fourth-quarter dividend of USD0.26 per share on the company's common stock, an 18% increase over the USD0.22 per share paid in the prior quarter.

This is the thirty-fourth consecutive annual increase in the company's dividend. The dividend is payable on November 18, 2026, to shareholders of record on November 11, 2026.